期刊文献+

二例肾脏病患者的药学监护 被引量:4

Drug uses for patients with kidney disease
下载PDF
导出
摘要 目的探讨临床药师在肾脏病患者合理用药中的作用。方法运用药学监护的一般方法对肾脏病患者实施药学监护,并结合实例进行分析。结果临床药师提供药学服务,提高了患者治疗依从性和临床治疗效果,减少了药物不良反应。结论临床药师在为患者提供个体化药学服务方面具有自身的优势和地位。 Objective To explore the role of clinical pharmacists care for patients with kidney disease in clinical rational drug use.Methods The common pharmaceutical care was applied to patients with kidney disease,and cases analysis was performed.Results The patients′ compliance and clinical outcomes were improved,and adverse drug reactions were decreased through pharmaceutical care provided by clinical pharmacists.Conclusion Clinical pharmacists have its own advantages and status in providing individualized pharmaceutical care for patients.
作者 陈菡
出处 《实用药物与临床》 CAS 2012年第6期356-358,共3页 Practical Pharmacy and Clinical Remedies
关键词 药学监护 糖尿病肾病 乙型肝炎病毒相关性肾炎 Pharmaceutical care Diabetic nephropathy Hepatitis B virus associated glomerulonephritis
  • 相关文献

参考文献14

二级参考文献64

共引文献74

同被引文献39

  • 1α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志,2005,21(7):421-424. 被引量:134
  • 2谌贻璞.用促红细胞生成素治疗肾性贫血必须合理补铁[J].肾脏病与透析肾移植杂志,2006,15(4):345-346. 被引量:37
  • 3陈香美,孙雪峰,蔡广研.重组人促红细胞生成素在肾性贫血中合理应用的专家共识[J].中国血液净化,2007,6(8):440-443. 被引量:109
  • 4National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and strati- fication[ J. Am J Kidney Dis, 2002, 39 (Suppl 2) : S1 -S246. 被引量:1
  • 5JOEL DK. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure[ JJ. Ant J Kidney Dis, 2001, 37(Suppl 2) S66 - S70. 被引量:1
  • 6National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kid- zey disease[J]. Am J Kidney Dis,2006,47(Suppl 3) : Sll - S145. 被引量:1
  • 7EDDINGTON H, HOEFIELD R, SINHA S, et al. Serum phos- phate and mortality in patients with chronic kidney disease [ J]. Clin ] Am Soc Nephrol, 2010,5(12) :2251 -2257. 被引量:1
  • 8EWENCE AE, BOOTMAN M, RODERICK HL, et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque de- stabilization[ J. Circ Res, 2008, 103 ( 5 ) : e28 - e34. 被引量:1
  • 9National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease J ]. Ant J Kidney Dis, 2003, 42( Suppl 3 ) :S1 - $201. 被引量:1
  • 10Yukihiko Kawasaki. The pathogenesis and treatment ofpediatric Henoch-Schonlein purpura nephritis [J]. Clin ExpNephrol, 2011,15(5):648-657. 被引量:1

引证文献4

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部